This page is intended for Investors and Commercial Partners
Leflutrozole (BGS649)
A novel once weekly oral aromatase inhibitor that has completed a Phase 2b study. STATUS: Partnered - ReproNovo SA
A novel once weekly oral aromatase inhibitor that has completed a Phase 2b study. STATUS: Partnered - ReproNovo SA